|
Market Closed -
NYSE
01:30:00 18/08/2026 am IST
|
5-day change | 1st Jan Change | ||
| 2.290 USD | +3.15% |
|
-7.66% | +27.22% |
| 12/08 | Protalix BioTherapeutics, Inc., Q2 2026 Earnings Call, Aug 12, 2026 | |
| 12/08 | Protalix BioTherapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Stock exchange
Quotes 5-day view: Protalix BioTherapeutics, Inc.
Delayed Quote NYSE
| 11/08/2026 | 12/08/2026 | 13/08/2026 | 14/08/2026 | 17/08/2026 | |
|---|---|---|---|---|---|
| Last | $2.430 | $2.620 | $2.360 | $2.220 | $2.290 |
| Volume | 3,73,852 | 20,12,469 | 20,01,846 | 9,95,919 | 10,75,616 |
| Change | -2.02% | +7.82% | -9.92% | -5.93% | +3.15% |
| Opening | $2.470 | $2.490 | $2.640 | $2.360 | $2.240 |
| High | $2.480 | $2.705 | $2.640 | $2.360 | $2.365 |
| Low | $2.410 | $2.400 | $2.320 | $2.170 | $2.220 |
Performance
| 1 day | +3.15% | ||
| 1 week | -7.66% | ||
| Current month | -3.38% | ||
| 1 month | -3.78% | ||
| 3 months | +15.66% | ||
| 6 months | -23.15% | ||
| Current year | +27.22% | ||
| 1 year | +54.73% | ||
| 3 years | +19.90% | ||
| 5 years | +67.15% | ||
| 10 years | -64.21% |
Volumes
marketsDaily volume
10,75,616
Estimated daily volume
10,75,616
Avg. Volume 20 sessions
8,44,594
Daily volume ratio
1.27
Avg. Volume 20 sessions USD
19,34,120.26
Record volume 1
19,12,89,000
Record volume 2
1,94,14,390
Record volume 3
1,27,16,823
Capital turnover ratio
0.01
Float rotation
0.01
Basic data
Market Cap (USD)
18,45,09,060
Net sales (USD)
5,27,44,000
Number of employees
226
Sales / Employee (USD)
2,33,381
Free-Float
96.12 %
Free-Float capitalization (USD)
17,73,54,175
Average Daily Capital Traded
1.05%
Indicators
Moving average 5 days
2.422
Moving average 20 days
2.391
Moving average 50 days
2.275
Moving average 100 days
2.199
Price spread / (MMA5)
+5.76%
Price spread / (MMA20)
+4.41%
Price spread / (MMA50)
-0.64%
Price spread / (MMA100)
-3.98%
STIM
RSI 9 days
46.25
RSI 14 days
49.22
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.15% | -7.66% | +54.73% | +19.90% | 18Cr | |
| +0.25% | -3.96% | +68.73% | +120.06% | 1,05500Cr | |
| +0.78% | +0.21% | +48.53% | +50.78% | 63TCr | |
| +0.35% | +0.95% | +21.11% | +66.86% | 44TCr | |
| +0.28% | -4.56% | +39.10% | +38.05% | 35TCr | |
| +0.78% | -2.68% | +24.03% | +37.32% | 29TCr | |
| +0.87% | -3.59% | -0.28% | +7.12% | 24TCr | |
| +1.00% | +0.52% | +41.46% | +58.95% | 23TCr | |
| -0.78% | -4.49% | -10.28% | -54.13% | 20TCr | |
| +0.40% | +4.40% | +17.36% | +81.59% | 17TCr | |
| Average | +0.71% | -2.06% | +30.45% | +42.65% | 36.13TCr | |
| Weighted average by Cap. | +0.44% | -1.70% | +39.71% | +63.88% |
Historical Quotes: Protalix BioTherapeutics, Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Latest transactions
fe19c4.pWVhQ7GlH4IA0oziSWnyizXbXML0p5i11UsPTFwXBdI.8gAHMtD1MvNwtNOwHQKY7FywCvbD_dzCpno3PQYjMKrwEikRhMlW7Wvg7w
| Date | Price | Volume | Total |
|---|---|---|---|
| 01:30:00 am | 2.290 | 28,725 | 9,81,853 |
| 01:29:57 am | 2.300 | 100 | 9,53,128 |
| 01:29:57 am | 2.300 | 100 | 9,53,028 |
| 01:29:57 am | 2.300 | 200 | 9,52,928 |
| 01:29:56 am | 2.300 | 100 | 9,52,728 |
| 01:29:56 am | 2.300 | 200 | 9,52,628 |
| 01:29:56 am | 2.300 | 500 | 9,52,428 |
| 01:29:56 am | 2.295 | 600 | 9,51,928 |
| 01:29:56 am | 2.300 | 100 | 9,51,328 |
| 01:29:56 am | 2.295 | 100 | 9,51,228 |
Course Extremes
| 1 week | 2.17 |  | 2.7 |
| 1 month | 2.17 | | 2.7 |
| Current year | 1.72 | | 3.19 |
| 1 year | 1.46 | | 3.19 |
| 3 years | 0.82 | | 3.19 |
| 5 years | 0.7 | | 3.55 |
| 10 years | 0.7 | | 15.15 |
Monthly variations
Annual variations
| 2026 | +27.22% | ||
| 2025 | -4.26% | ||
| 2024 | +5.62% | ||
| 2023 | +29.93% | ||
| 2022 | +64.72% | ||
| 2021 | -77.09% | ||
| 2020 | +10.67% | ||
| 2019 | +5.47% | ||
| 2018 | -52.96% | ||
| 2017 | +48.58% | ||
| 2016 | -56.37% | ||
| 2015 | -44.57% | ||
| 2014 | -52.70% | ||
| 2013 | -25.05% | ||
| 2012 | +5.27% | ||
| 2011 | -50.60% | ||
| 2010 | +50.76% | ||
| 2009 | +259.78% | ||
| 2008 | -45.88% | ||
| 2007 | -87.48% |
- Stock Market
- Stocks
- PLX Stock
- Quotes Protalix BioTherapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
